Nutrition and DialysisSurvival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters☆,☆☆
Section snippets
Patients
Five hundred thirty-seven HD patients and 422 PD patients treated at the Long Island College Hospital’s outpatient dialysis facilities were enrolled in this study from 1987 to 1999. For the prealbumin study, 126 HD and 116 PD patients were enrolled beginning June 1991. The patients were followed up to January 1, 2000. Follow-up was censored on transplantation, transfer of dialysis modality, or transfer to another dialysis center. On enrollment, the following demographic and clinical data were
Patient characteristics
Table 1 describes the demographic, clinical, and biochemical characteristics of HD and PD patients. The causes of renal failure were similar in the two dialysis modalities except for a higher proportion of human immunodeficiency virus (HIV) infection (7.9% v 1.7%) in PD patients.
Discussion
We have shown that HD patients had 44% lower mortality risk than those patients treated with PD. Our results are in agreement with those of Lowrie et al1 and Bloembergen et al.2 The mortality risk for diabetic PD patients was more than twice that of diabetic HD patients (P < 0.0001) which is in agreement with findings by Held et al.10 Our study is unique in that we have followed a large number of patients in a single center for up to 12 years. The most likely explanation for excess mortality in
References (14)
- et al.
Death risk predictors among peritoneal dialysis and hemodialysis patients: A preliminary comparison
Am J Kidney Dis
(1995) - et al.
Mortality risks of peritoneal dialysis and hemodialysis
Am J Kidney Dis
(1999) - et al.
Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates
Am J Kidney Dis
(1997) - et al.
Comparative mortality of hemodialysis and peritoneal dialysis in Canada
Kidney Int
(2000) - et al.
Markers for survival in dialysis: A seven year prospective study
Am J Kidney Dis
(1995) - et al.
Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers
Am J Kidney Dis
(1994) - et al.
Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia
Am J Kidney Dis
(1996)
Cited by (77)
Association of malnutrition in peritoneal dialysis patients of Saudi Arabia
2016, Arabian Journal of ChemistryLow prealbumin levels are independently associated with higher mortality in patients on peritoneal dialysis
2016, Kidney Research and Clinical PracticeCitation Excerpt :In our study, the AUC value of prealbumin for mortality was the largest among the various nutritional parameters, whereas serum albumin did not reach a clinically significant relationship with mortality by AUC and multivariate analyses. On the contrary, Avram et al [7] reported that serum albumin is an independent predictor of mortality in patients on PD (relative risk, 0.52) in the univariate regression model, and higher enrollment level of serum albumin is associated with better survival [29]. Moreover, a low serum albumin level had been used as an indicator of malnutrition in dialysis patients [30].
Nutrition and the Kidney: Recommendations for Peritoneal Dialysis
2013, Advances in Chronic Kidney DiseaseCitation Excerpt :Because of its shorter half-life in patients without CKD, serum transthyretin (prealbumin) has been suggested to be a better nutritional marker compared with albumin. In a large cohort study, a reduced prealbumin concentration was shown to correlate to albumin and other laboratory surrogate markers and to be associated with an increased risk of mortality.18 However, large studies comparing prealbumin concentration to other nutritional measures in PD are lacking.
Protein-Energy Wasting as a Risk Factor of Morbidity and Mortality in Chronic Kidney Disease
2013, Nutritional Management of Renal Disease
- ☆
Supported by National Kidney Foundation of New York/New Jersey and Nephrology Foundation of Brooklyn.
- ☆☆
Address reprint requests to Morrell M. Avram, MD, FACP, Avram Division of Nephrology, Long Island College Hospital, 339 Hicks Street, Brooklyn, NY 11201. E-mail: [email protected]